Down 39%. Is Novo Nordisk Stock a Buy on the Dip?
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Medical Marketing & Media1d
Novo Nordisk welcomes patients to the Ozempic Era
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
Are weight-loss drugs like Ozempic a forever medicine? Vikrant Shrotriya of Novo Nordisk India reacts
As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much ...
Novo Nordisk Launches National "My Ozempic® Era" Campaign Celebrating Stories of Inspirational Ozempic® Patients
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
How Long Should I Stay on Ozempic For Weight Loss?
You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...
The Hill3d
Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy
Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will ... recently confirming that both Wegovy and Ozempic, forms of the GLP-1 medication semaglutide, are no longer in shortage ...
Novo Nordisk Stock Rises on Weight-Loss Retreat by Hims & Hers
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
India Today on MSN1d
Why don't celebrities admit to taking Ozempic? Expert answers at India Today Conclave
Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...